Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 1 | |
Outperform | 5 | |
Hold | 1 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in EUR
The 6 analysts offering 12 month price targets for ProQR Therapeutics NV have a median target of 5.07, with a high estimate of 6.08 and a low estimate of 2.18. The median estimate represents a 184.68% increase from the last price of 1.78.
High | 241.7% | 6.08 |
Med | 184.7% | 5.07 |
Low | 22.3% | 2.18 |
Earnings history & estimates in EUR
The next earnings announcement is expected on Nov 08, 2024.
Average growth rate | +17.02% |
Average growth rate | +24.03% |
More ▼
Revenue history & estimates in EUR
Average growth rate | +94.31% |
Average growth rate | +129.68% |
More ▼